EUVIMEDEUVIMED entdecken
Crossref

Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2

Mei-Xia Xu, Tao Xu, Ning An

Current Medical Science · 2024

DOI: 10.1007/s11596-024-2940-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Medical Science, 2024. Verfasst von Mei-Xia Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Wuhan Fourth Hospital, Wuhan, 430033, China. Hauptthemen laut MEDLINE: MicroRNAs, Pulmonary Fibrosis, Bleomycin, Respiratory Distress Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Acute respiratory distress syndrome (ARDS) patients currently have relatively high mortality, which is associated with early lung fibrosis. This study aimed to investigate whether miR-17 suppression could alleviate ARDS-associated lung fibrosis by regulating Mfn2. METHODS: A mouse model of ARDS-related lung fibrosis was constructed via intratracheal instillation of bleomycin. The expression level of miR-17 in lung tissues was detected via quantitative real time polymerase chain reaction (qRT-PCR). In the ARDS mouse model of lung fibrosis, the mitigating effects of miR-17 interference were evaluated via tail vein injection of the miR negative control or the miR-17 antagomir. The pathological changes in the lung tissue were examined via HE staining and Masson's trichrome staining, and the underlying molecular mechanism was investigated via ELISA, qRT-PCR and Western blotting. RESULTS: Bleomycin-induced pulmonary fibrosis significantly increased collagen deposition and the levels of hydroxyproline (HYP) and miR-17. Interfering with miR-17 significantly reduced the levels of HYP and miR-17 and upregulated the expression of Mfn2. The intravenous injection of the miR-17 antagomir alleviated lung inflammation and reduced collagen deposition. In addition, interference with miR-17 could upregulate LC3B expression, downregulate p62 expression, and improve mitochondrial structure. CONCLUSION: Interfering with miR-17 can improve pulmonary fibrosis in mice by promoting mitochondrial autophagy via Mfn2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPulmonary FibrosisBleomycinRespiratory Distress SyndromeDisease Models, AnimalGTP PhosphohydrolasesAnimalsMiceMaleLungMitochondrial ProteinsGene Expression RegulationHydroxyprolineAntagomirsHumans

Stichwörter der Autor:innen

Mfn2acute respiratory distress syndromemiR-17mitochondriapulmonary fibrosis

Substanzen

MicroRNAsMfn2 protein, mouseBleomycinMirn17 microRNA, mouseGTP PhosphohydrolasesMitochondrial ProteinsHydroxyprolineAntagomirs

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Wuhan Fourth Hospital, Wuhan, 430033, China.
  • Department of Critical Care Medicine, Wuhan Fourth Hospital, Wuhan, 430033, China. 5955098@qq.com.
  • Institute of Anesthesiology and Critical Care, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. 2009xh0867@hust.edu.cn.

Zitieren

APA

Xu, M. X., Xu, T., & An, N. (2024). Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2. Current Medical Science. https://doi.org/10.1007/s11596-024-2940-9

Vancouver

Xu MX, Xu T, An N. Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2. Current Medical Science. 2024. doi:10.1007/s11596-024-2940-9

BibTeX
@article{Xu2024,
  author = {Xu, Mei-Xia and Xu, Tao and An, Ning},
  title = {Suppression of miR-17 Alleviates Acute Respiratory Distress-associated Lung Fibrosis by Regulating Mfn2},
  journal = {Current Medical Science},
  year = {2024},
  doi = {10.1007/s11596-024-2940-9}
}
Kostenlos starten →